GLP-1 is released after food intake and acts to amplify glucose-dependent insulin secretion, and it has been in the spotlight as a target for the treatment of obesity and diabetes as its positive effects on glucose homeostasis, appetite regulation, gastric emptying and postprandial lipid metabolism (26, 27). Here, GCG is linked to obesity due to melanocortin 4 receptor deficiency.